Compound E, chemically designated as 209986-17-4, represents a significant study within the field of Alzheimer's disease research. This γ-secretase modulator was initially developed as a promising therapeutic https://alyssadcmk484022.activoblog.com/51134816/γ-secretase-inhibitor-compound-e-209986-17-4